Le Lézard
Classified in: Health, Science and technology
Subjects: PDT, PLW, MAT

NanoSphere Health Sciences Awarded Breakthrough Patent for Disruptive Nanoparticle Delivery Platform


Landmark patent marks most significant advancement in over 25 years for non-invasive medical delivery systems 

DENVER, March 27, 2018 /PRNewswire/ -- NanoSphere Health Sciences INC (CSE: NSHS) (OTC: NSHSF) is pleased to announce that its flagship subsidiary, NanoSphere Health Sciences, LLC, has been granted Patent No. 9,925.149?which covers the core technology behind the production of the NanoSphere Delivery Systemtm?by the United States Patent and Trademark Office.

Photo Credit: NanoSphere Health Sciences

The research-proven NanoSphere Delivery Systemtm, protected by this patent, is one of the most important advancements for the non-invasive delivery of biological agents in over 25 years. The patent broadly encompasses the formation and manufacturing of the NanoSphere Delivery Systemtm for the delivery of cannabinoids, pharmaceuticals, nutraceuticals, cosmeceuticals and other biological agents.

NanoSphere's groundbreaking NanoSphere Delivery Systemtm nanoencapsulates a broad range of bioactive compounds in a protective membrane, transporting them rapidly and effectively to the bloodstream and cells for greater efficacy. This delivery platform is a breakthrough in pharmaceutical, cannabinoid, nutraceutical and cosmeceutical supplement delivery. It makes the nanoencapsulated agents safer and more bioavailable, reducing adverse effects by delivering precise doses of smart nanoparticles to target sites.

"The granting of the patent for the NanoSphere Delivery Systemtm secures our position as a leader in advanced nanoparticle delivery," said Robert Sutton, CEO of NanoSphere Health Sciences. "Major industries have the potential to be reshaped and reimagined by our next-generation technology."

"NanoSphere's patent claims and protects our core technology for the formation and manufacturing of lipid, structural nanoparticles, which is the NanoSphere Delivery Systemtm," said Dr. Richard Clark Kaufman, Chief Science Officer and inventor of the NanoSphere Delivery Systemtm. "This patent extends to our 16 forms of lipid nanoparticle structures, which can be applied across healthcare sectors for vastly improved medical delivery."

With the issuance of this patent, the NanoSphere will now have long-term market exclusivity over this delivery platform, with patent infringement prohibited. The company intends to license the patented NanoSphere Delivery Systemtm and proprietary manufacturing process to selected companies in its target industries to maximize commercialization. This patent allows NanoSphere to bring to the world the NanoSphere Delivery Systemtm through multiple product lines and platforms, such as the company's cannabis brand Evolve Formulas' transdermal, intranasal and intraoral applications and beyond.

For more information or media inquiries, contact Emily Kielthy at [email protected] or 646-695-7045.

On behalf of the Board:
Robert Sutton, Chairman & CEO, [email protected]

Investor Contact:
David Sutton, President & COO / [email protected] / 303.887.9300
Victor Goncalves, Executive Vice President / [email protected] / 204-997-5517

The Canadian Securities Exchange does not accept responsibility for the adequacy or accuracy of this release.

NanoSphere's Commitment to Licensing IP

NanoSphere launched its IP licensing program in 2015 and is entertaining several licensing opportunities via a rigorous evaluation process. For more information about NanoSphere's licensing program, please visit: https://www.nanospherehealth.com/licensing/

About NanoSphere

NanoSphere Health Sciences LLC, a subsidiary of NanoSphere Health Sciences INC (CSE: NSHS) (OTC: NSHSF), is the leader in nanoparticle delivery, a biotechnology company advancing the NanoSphere Delivery Systemtm.  NanoSphere's patented core technology is changing the way biological agents deliver benefits.   

NanoSphere's disruptive platforms use smart nanoparticles to deliver cannabinoids, nutraceuticals, pharmaceuticals and over-the-counter medications in a patented process with greater bioavailability and efficacy for the cannabis, nutraceutical, pharmaceutical, cosmeceutical and animal health industries.  For more information on NanoSphere, please visit http://www.nanospherehealth.com.

Forward Looking Statement Caution

This news release includes forward looking statements that are subject to assumptions, risks and uncertainties. Statements in this news release which are not purely historical are forward looking statements, including without limitation any statements concerning the Company's intentions, plans, estimates, expectations or beliefs regarding the future. Although the Company believes that any forward looking statements in this news release are reasonable, there can be no assurance that any such forward looking statements will prove to be accurate. The Company cautions readers that all forward looking statements, including without limitation those relating to the Company's future operations and business prospects, are based on assumptions none of which can be assured, and are subject to certain risks and uncertainties that could cause actual events or results to differ materially from those indicated in the forward looking statements. Readers are advised to rely on their own evaluation of such risks and uncertainties and should not place undue reliance on forward looking statements. Any forward looking statements are made as of the date of this news release, and the Company assumes no obligation to update the forward looking statements, or to update the reasons why actual events or results could or do differ from those projected in the forward looking statements, whether as a result of new information, future events or otherwise.

 

NanoSphere Health Sciences is providing next-generation delivery of nutraceuticals & supplements, over-the-counter medications for the cannabis, pharmaceutical, and animal health products, and beyond. Cutting-edge NanoSphere Delivery Systemstm are up to 6 times more bioavailable and improve product quality. Patent-pending NanoSpheres provide superior delivery of a wide-range of bioactive compounds. NanoSphere Health Sciences helps people achieve better health more rapidly and effectively. (PRNewsfoto/NanoSphere Health Sciences, LLC)

SOURCE NanoSphere Health Sciences INC


These press releases may also interest you

at 04:00
Halfpricesoft.com offers a seamless and secure solution for in-house payroll processing with the l atest 2024 ezPaycheck YTD feature for those switching to the program, mid-year. The application is also combine d with features that have long...

at 04:00
U Power Limited (the "Company" or "U Power"), a vehicle sourcing services provider with a vision to becoming a comprehensive EV battery power solution provider in China, today announced that the Company held an extraordinary general meeting of...

at 04:00
"The tourism data for Milan in 2023 reached an all-time high, and it's a success we must share among many stakeholders, both public and private, including the dense network of accommodation facilities in the city. We need virtuous examples like Hotel...

at 03:59
Timekettle, a fast-growing cross-language communication solutions innovator, has successfully wrapped up its #SpringTravelWithTimekettle campaign on Instagram. Running from March 18 to 24, Timekettle encouraged global travelers to share their...

at 03:52
The progressive decrease in hearing in elderly people can represent a major problem for their quality of life: it has in fact been demonstrated that critical issues such as these, in addition to being a problem as such, can...

at 03:44
Bitrue, a leading cryptocurrency exchange serving over 10 million users globally, announces a focus on user behavior analysis to further develop the utility of its native token, Bitrue Coin (BTR). "Understanding how our users interact with BTR is...



News published on and distributed by: